Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the molecular origins of the chronic myeloproliferative disorders: it all makes sense.

× No keyword cloud information.

30 in total

Review 1. JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?

Authors: Linda M Scott; Vivienne I Rebel
Journal: Am J Hematol Date: 2012-05-28 Impact factor: 10.047

Review 2. Megakaryocyte biology and related disorders.

Authors: Liyan Pang; Mitchell J Weiss; Mortimer Poncz
Journal: J Clin Invest Date: 2005-12 Impact factor: 14.808

3. Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7.

Authors: Stefan Fröhling; Daniel B Lipka; Sabine Kayser; Claudia Scholl; Richard F Schlenk; Hartmut Döhner; D Gary Gilliland; Ross L Levine; Konstanze Döhner
Journal: Blood Date: 2006-02-01 Impact factor: 22.113

4. Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders.

Authors: S E Langabeer; F Ni Ainle; E Conneally; M Lawler
Journal: Ir J Med Sci Date: 2007-04-18 Impact factor: 1.568

5. Studies of c-Mpl function distinguish the replication of hematopoietic stem cells from the expansion of differentiating clones.

Authors: Janis L Abkowitz; Jing Chen
Journal: Blood Date: 2007-03-08 Impact factor: 22.113

6. Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status.

Authors: Oliver Bock; Johanne Neuse; Kais Hussein; Kai Brakensiek; Guntram Buesche; Thomas Buhr; Birgitt Wiese; Hans Kreipe
Journal: Am J Pathol Date: 2006-08 Impact factor: 4.307

Review 7. JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors: David P Steensma
Journal: J Mol Diagn Date: 2006-09 Impact factor: 5.568

On the molecular origins of the chronic myeloproliferative disorders: it all makes sense.